BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hornberger J, Holodniy M, Robertus K, Winnike M, Gibson E, Verhulst E. A Systematic Review of Cost-Utility Analyses in HIV/AIDS: Implications for Public Policy. Med Decis Making 2007;27:789-821. [DOI: 10.1177/0272989x07306112] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Tan DHS, Hull MW, Yoong D, Tremblay C, O'Byrne P, Thomas R, Kille J, Baril JG, Cox J, Giguere P, Harris M, Hughes C, MacPherson P, O'Donnell S, Reimer J, Singh A, Barrett L, Bogoch I, Jollimore J, Lambert G, Lebouche B, Metz G, Rogers T, Shafran S; Biomedical HIV Prevention Working Group of the CIHR Canadian HIV Trials Network. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis. CMAJ 2017;189:E1448-58. [PMID: 29180384 DOI: 10.1503/cmaj.170494] [Cited by in Crossref: 101] [Cited by in F6Publishing: 105] [Article Influence: 16.8] [Reference Citation Analysis]
2 Zou H, Meng X, Grulich A, Huang S, Jia T, Zhang X, Luo Z, Ding Y, Yang L, Huang J, Chen W, Zheng H, Yang B. A randomised controlled trial to evaluate the impact of sexual health clinic based automated text message reminders on testing of HIV and other sexually transmitted infections in men who have sex with men in China: protocol for the T2T Study. BMJ Open 2017;7:e015787. [PMID: 28698334 DOI: 10.1136/bmjopen-2016-015787] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
3 Tran BX, Nguyen LH, Ohinmaa A, Maher RM, Nong VM, Latkin CA. Longitudinal and cross sectional assessments of health utility in adults with HIV/AIDS: a systematic review and meta-analysis. BMC Health Serv Res 2015;15:7. [PMID: 25609449 DOI: 10.1186/s12913-014-0640-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
4 Holtgrave DR, Wolitski RJ, Pals SL, Aidala A, Kidder DP, Vos D, Royal S, Iruka N, Briddell K, Stall R, Bendixen AV. Cost-utility analysis of the housing and health intervention for homeless and unstably housed persons living with HIV. AIDS Behav 2013;17:1626-31. [PMID: 22588529 DOI: 10.1007/s10461-012-0204-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
5 Chesson HW, Pinkerton SD, Holtgrave DR. Distribution of Prevention Resources and Impact on Sexual Health in the USA. The New Public Health and STD/HIV Prevention 2013. [DOI: 10.1007/978-1-4614-4526-5_7] [Reference Citation Analysis]
6 Holtgrave DR, Maulsby C, Wehrmeyer L, Hall HI. Behavioral factors in assessing impact of HIV treatment as prevention. AIDS Behav 2012;16:1085-91. [PMID: 22491813 DOI: 10.1007/s10461-012-0186-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
7 Rawizza HE, Chaplin B, Meloni ST, Eisen G, Rao T, Sankalé JL, Dieng-Sarr A, Agbaji O, Onwujekwe DI, Gashau W, Nkado R, Ekong E, Okonkwo P, Murphy RL, Kanki PJ; APIN PEPFAR Team. Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. Clin Infect Dis 2011;53:1283-90. [PMID: 22080121 DOI: 10.1093/cid/cir729] [Cited by in Crossref: 110] [Cited by in F6Publishing: 113] [Article Influence: 10.0] [Reference Citation Analysis]
8 Nosyk B, Montaner JS. The evolving landscape of the economics of HIV treatment and prevention. PLoS Med 2012;9:e1001174. [PMID: 22347816 DOI: 10.1371/journal.pmed.1001174] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
9 Anstee S, Price A, Young A, Barnard K, Coates B, Fraser S, Moran R. Developing a matrix to identify and prioritise research recommendations in HIV prevention. BMC Public Health 2011;11:381. [PMID: 21609477 DOI: 10.1186/1471-2458-11-381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
10 Leibowitz AA, Parker KB, Rotheram-Borus MJ. A US policy perspective on oral preexposure prophylaxis for HIV. Am J Public Health 2011;101:982-5. [PMID: 21493945 DOI: 10.2105/AJPH.2010.300066] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
11 Reed SD, Scales CD Jr, Stewart SB, Sun J, Moul JW, Schulman KA, Xu J. Effects of family history and genetic polymorphism on the cost-effectiveness of chemoprevention with finasteride for prostate cancer. J Urol 2011;185:841-7. [PMID: 21239023 DOI: 10.1016/j.juro.2010.10.078] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
12 Emmett SD, Cunningham CK, Mmbaga BT, Kinabo GD, Schimana W, Swai ME, Bartlett JA, Crump JA, Reddy EA. Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study. J Acquir Immune Defic Syndr 2010;54:368-75. [PMID: 20216225 DOI: 10.1097/QAI.0b013e3181cf4882] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
13 Bertrand JT, Holtgrave DR, Gregowski A. Evaluating HIV/AIDS programs in the USand developing countries. HIV Prevention 2009. [DOI: 10.1016/b978-0-12-374235-3.00021-2] [Reference Citation Analysis]